» Articles » PMID: 33939310

Baicalein Alleviates Osteoarthritis by Protecting Subchondral Bone, Inhibiting Angiogenesis and Synovial Proliferation

Overview
Journal J Cell Mol Med
Date 2021 May 3
PMID 33939310
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoarthritis (OA) is one of the most frequent chronic joint diseases with the increasing life expectancy. The main characteristics of the disease are loss of articular cartilage, subchondral bone sclerosis and synovium inflammation. Physical measures, drug therapy and surgery are the mainstay of treatments for OA, whereas drug therapies are mainly limited to analgesics, glucocorticoids, hyaluronic acids and some alternative therapies because of single therapeutic target of OA joints. Baicalein, a traditional Chinese medicine extracted from Scutellaria baicalensis Georgi, has been widely used in anti-inflammatory therapies. Previous studies revealed that baicalein could alleviate cartilage degeneration effectively by acting on articular chondrocytes. However, the mechanisms involved in baicalein-mediated protection of the OA are not completely understood in consideration of integrality of arthrosis. In this study, we found that intra-articular injection of baicalein ameliorated subchondral bone remodelling. Further studies showed that baicalein could decrease the number of differentiated osteoblasts by inhibiting pre-osteoblasts proliferation and promoting pre-osteoblasts apoptosis. In addition, baicalein impaired angiogenesis of endothelial cells and inhibited proliferation of synovial cells. Taken together, these results implicated that baicalein might be an effective medicine for treating OA by regulating multiple targets.

Citing Articles

A Baicalin-Based Functional Polymer in Dynamic Reversible Networks Alleviates Osteoarthritis by Cellular Interactions.

Yang Y, Hu Q, Shao Q, Peng Y, Yu B, Luo F Adv Sci (Weinh). 2025; 12(10):e2410951.

PMID: 39840483 PMC: 11904974. DOI: 10.1002/advs.202410951.


Effects of Baicalein Pretreatment on the NLRP3/GSDMD Pyroptosis Pathway and Neuronal Injury in Pilocarpine-Induced Status Epilepticus in the Mice.

Kang J, Mo S, Shu X, Cheng S eNeuro. 2024; 12(1.

PMID: 39662962 PMC: 11728850. DOI: 10.1523/ENEURO.0319-24.2024.


Baicalein suppresses inflammation and attenuates acute lung injury by inhibiting glycolysis via HIF‑1α signaling.

Liu Z, Zheng X, Li N, Wang Z Mol Med Rep. 2024; 31(1).

PMID: 39513601 PMC: 11564906. DOI: 10.3892/mmr.2024.13383.


Novel formulations ameliorate osteoarthritis in rats by inhibiting inflammation and oxidative stress.

Erten F, Ozdemir O, Tokmak M, Durmus A, Ozercan I, Morde A Food Sci Nutr. 2024; 12(10):7896-7912.

PMID: 39479600 PMC: 11521736. DOI: 10.1002/fsn3.4407.


Amentoflavone maintaining extracellular matrix homeostasis and inhibiting subchondral bone loss in osteoarthritis by inhibiting ERK, JNK and NF-κB signaling pathways.

Liang J, Hu J, Hong X, Zhou M, Xia G, Hu L J Orthop Surg Res. 2024; 19(1):662.

PMID: 39407273 PMC: 11481797. DOI: 10.1186/s13018-024-05075-2.


References
1.
Henrotin Y, Pesesse L, Sanchez C . Subchondral bone and osteoarthritis: biological and cellular aspects. Osteoporos Int. 2012; 23 Suppl 8:S847-51. DOI: 10.1007/s00198-012-2162-z. View

2.
Bie B, Sun J, Guo Y, Li J, Jiang W, Yang J . Baicalein: A review of its anti-cancer effects and mechanisms in Hepatocellular Carcinoma. Biomed Pharmacother. 2017; 93:1285-1291. DOI: 10.1016/j.biopha.2017.07.068. View

3.
Park Y, Choi J, Jung H, Kim B, Kim C, Park S . Baicalein inhibits tumor progression by inhibiting tumor cell growth and tumor angiogenesis. Oncol Rep. 2017; 38(5):3011-3018. DOI: 10.3892/or.2017.6007. View

4.
Zhang X, Zhu Y, Chen X, Zhang Y, Zhang Y, Jia Y . Baicalein ameliorates inflammatory-related apoptotic and catabolic phenotypes in human chondrocytes. Int Immunopharmacol. 2014; 21(2):301-8. DOI: 10.1016/j.intimp.2014.05.006. View

5.
Shi C, Huang P, Kang H, Hu B, Qi J, Jiang M . Glucocorticoid inhibits cell proliferation in differentiating osteoblasts by microRNA-199a targeting of WNT signaling. J Mol Endocrinol. 2015; 54(3):325-37. DOI: 10.1530/JME-14-0314. View